FindTrial
Sign In

Culturing of Pseudomonas aeruginosa bacteria taken from ear discharge swab and checking the sensitivity of Rohitaka drug on it

IN VITRO STUDY OF PSEUDOMONAS AERUGINOSA THROUGH PUS CULTURE AND SENSITIVITY USING ROHITAKA IN KARNA SRAVA WITH REFERENCE TO CHRONIC SUPPURATIVE OTITIS MEDIA - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/07/113612
Enrollment
30
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H663- Other chronic suppurative otitis media

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr Spoorti R D
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who have not taken any antibiotics either topical or systemic for the last 7 days

Exclusion criteria

Exclusion criteria: Post operative discharging cavities were excluded from the study Complicated cases of CSOM like intracranial complications Petrositis Labyrinthitis and Facial nerve palsy were excluded from the study Immunocompromised patients Anaerobic bacterial and fungal culture positive patients sample

Design outcomes

Primary

MeasureTime frame
To Isolate and Identify Pseudomonas aeruginosa involved in Karna srava through pus cultureTimepoint: 4 weeks—

Secondary

MeasureTime frame
To study the sensitivity of Rohitaka against Pseudomonas aeruginosa involved in Karna sravaTimepoint: 4 weeks—

Countries

India

Contacts

Public ContactDr SPOORTI RD

Government Ayurveda Medical College Bengaluru

drandanagoudapatil@gmail.com9448980885

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026